SMI Adviser
無料
1.4.1for iPhone, iPod touch
9.9
12 Ratings
American Psychiatric Association
Developer
63.7MB
Size
2024年04月30日
Update Date
Medical
Category
17+
Age Rating
Age Rating
SMI Adviser スクリーンショット
About SMI Adviser
Submit questions, access resources, and receive guidance from national experts in SMI.
Our mission is to advance the use of a person-centered approach to care that ensures people who have SMI find the treatment and support they need. For clinicians, we offer access to education, data, and consultations so you can make evidence-based treatment decisions. For individuals, families, friends, people who have questions, or people who care for someone with SMI, we offer access to resources and answers from a national network of experts. SMI Adviser is funded by the Substance Abuse and Mental Health Services Administration (SAMHSA) and administered by the American Psychiatric Association (APA).
Funding for this initiative was made possible (in part) by Grant No. 1H79SM080818-01 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
*****
SMI Adviser is provided for general educational and informational purposes. It should not be construed as medical advice in connection with the care of a particular patient or as a statement of the standard of care. It is not necessarily inclusive of all potential treatments. The activities and materials offered through SMI Adviser should not be considered as providing the basis for any certification or authorization to prescribe or administer medication. SMI Adviser is not intended to be a substitute for independent professional medical advice, diagnosis or treatment. SMI Adviser does not endorse or recommend any pharmaceutical or other treatment as an appropriate course for any particular patient or condition. The advice of a physician or other qualified health provider should be obtained for a treatment recommendation or to answer any questions regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen on SMI Adviser. SMI Adviser is provided as-is and is not guaranteed to be correct, complete or current. APA makes no warranty, expressed or implied, about the accuracy, applicability, fitness, completeness or reliability of the information contained within SMI Adviser. APA assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of SMI Adviser or for any errors or omissions. The limitations applicable to the SMI Adviser consultation feature are set forth at: https://smiadviser.org/limitations-of-consultation
Our mission is to advance the use of a person-centered approach to care that ensures people who have SMI find the treatment and support they need. For clinicians, we offer access to education, data, and consultations so you can make evidence-based treatment decisions. For individuals, families, friends, people who have questions, or people who care for someone with SMI, we offer access to resources and answers from a national network of experts. SMI Adviser is funded by the Substance Abuse and Mental Health Services Administration (SAMHSA) and administered by the American Psychiatric Association (APA).
Funding for this initiative was made possible (in part) by Grant No. 1H79SM080818-01 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
*****
SMI Adviser is provided for general educational and informational purposes. It should not be construed as medical advice in connection with the care of a particular patient or as a statement of the standard of care. It is not necessarily inclusive of all potential treatments. The activities and materials offered through SMI Adviser should not be considered as providing the basis for any certification or authorization to prescribe or administer medication. SMI Adviser is not intended to be a substitute for independent professional medical advice, diagnosis or treatment. SMI Adviser does not endorse or recommend any pharmaceutical or other treatment as an appropriate course for any particular patient or condition. The advice of a physician or other qualified health provider should be obtained for a treatment recommendation or to answer any questions regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen on SMI Adviser. SMI Adviser is provided as-is and is not guaranteed to be correct, complete or current. APA makes no warranty, expressed or implied, about the accuracy, applicability, fitness, completeness or reliability of the information contained within SMI Adviser. APA assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of SMI Adviser or for any errors or omissions. The limitations applicable to the SMI Adviser consultation feature are set forth at: https://smiadviser.org/limitations-of-consultation
Show More
最新バージョン 1.4.1 の更新情報
Last updated on 2024年04月30日
旧バージョン
- Knowledge Base updates
Show More
Version History
1.4.1
2024年04月30日
- Knowledge Base updates
1.4
2024年03月26日
- New interactive tool for clinicians: App Evaluation Screener
1.3.4
2023年12月22日
- Updates to LAI dose conversion tool
1.3.3
2023年08月17日
- Updated conversion information for Risperidone in LAI Conversion Tool
1.3.2
2023年08月10日
- New tool to help predict clozapine level and dose needed to achieve that level based on smoking status, sex, weight, and age.
1.3.1
2023年06月15日
- New tool to convert oral to long-acting injectable antipsychotics.
1.3
2023年05月10日
- Improved education catalog
1.2.7
2022年12月01日
- Bug Fixes
1.2.6
2022年07月15日
- Bug Fixes
1.2.5
2022年04月13日
- Added new Questionnaire: Alcohol Use Disorders Identification Test-Concise (AUDIT-C).
- Added PDF sharing functionality for all Questionnaires.
- Added PDF sharing functionality for all Questionnaires.
1.2.4
2021年12月02日
- Minor Bug Fixes
1.2.3
2021年08月05日
- AIMS Rating Scale
- Bug Fixes
- Bug Fixes
1.2.2
2020年08月20日
- Bug Fixes
1.2.1
2019年12月31日
- Bug Fixes
1.2
2019年12月20日
- Rating scale DAST-10
- Rating scale PROMIS-V1.2
- Rating scale PROMIS-V1.2
1.1.3
2019年11月18日
- Performance Improvements
1.1.2
2019年11月01日
- Global Search in Education Catalog and Knowledge Base
- Bug Fixes
- Bug Fixes
1.1
2019年09月25日
Performance improvements and bug fixes.
1.0
2019年09月16日
SMI Adviser FAQ
ここをクリック!地理的に制限されているアプリのダウンロード方法をご参考ください。
次のリストをチェックして、SMI Adviserの最低システム要件をご確認ください。
iPhone
iOS 12.0以降が必要です。
iPod touch
iOS 12.0以降が必要です。
SMI Adviserは次の言語がサポートされています。 英語